During the COVID-19 pandemic, patients’ fear of getting infected in healthcare settings prompted many to use telehealth from the comfort of their own home. That has come with a number of advantages. As telehealth becomes more and more popular, many providers and patients alike appreciate the ease and convenience of home doctor appointments and it has helped patients who have difficulty accessing with health care — because they live far from a provider or because a health condition makes it difficult to move.
But remote appointments have made certain types of care and follow-up more difficult. For example, without touching the patient, it is more difficult to check vital signs.
[time-brightcove not-tgx=”true”]
Companies exhibiting their inventions at 2022 CES technology conference trying to fill that void. Their innovations are providing new ways for patients to connect with healthcare providers while gathering new sources of information about patient health. These data have the potential to give healthcare providers a more complete picture of their patients — and deliver more personalized and capable care. . Here are some notable innovations at CES 2022 that aim to make telehealth more useful.
Abbott’s NeuroSphere Virtual Clinic
Abbott’s NeuroSphere Virtual Clinic The app provides patients with a platform where they can video chat with doctors and access treatments remotely. While the patient sits in their living room, their doctor can connect to their implanted medical device over WiFi and telemedicine conducts treatments for chronic pain and movement disorders such as Parkinson’s disease, including spinal stimulation, dorsal root ganglionectomy, and deep brain stimulation therapy. Patients can also perform therapy on their own and access specified stimulation settings on their smartphones. The Virtual Clinic received approval from the US Food and Drug Administration (FDA) in March.
During Abbott’s demonstration of the tool at CES, Dr Fiona Gupta, director of the Movement Disorders Outreach Program at Mount Sinai Health System and an assistant professor of neurology, said a one of the advantages of the tool is how she can see her patients. move around the spaces where they will stay the most: their own homes. “They can show me how they play the piano, how they interact with their pets, and how they navigate their kitchen,” says Gupta. “This gives me the opportunity to personalize their deep brain stimulation and help them keep doing the things they love to do.”
EarlySense’s InSight at home
Many of the new tools that connect patients to their healthcare provider require the patient to interact with a device, but EarlySense InSight at Home only requires them to sleep in their own bed. The sensor, which is placed under a person’s mattress, collects overnight data on breathing patterns, heart rate and body movements, and flags problems such as an unstable heart rate or impaired respiratory rate. The sensor then uses AI algorithms and models to detect changes in the patient’s health and uploads the data to the Early Sense cloud, which can be integrated into a care system or dashboard patient. It is expected to be widely available in the second half of 2022.
Jasper Health Digital Oncology Platform
Getting cancer treatment can never be easy, but Jasper . Digital Oncology Platform aim to make it more organized. It allows patients to track their care — by recording appointments, medications, and symptoms — and connects them to support, which includes specialists who can answer patient questions. core. Jasper can also connect patients to clinical care and case management by linking to biometric monitoring devices.
BioIntelliSense’s BioSticker and BioButton
Some wearables today can not only record a patient’s vital signs, but can also transmit them directly to their doctor. Two of the new tools are BioSticker and BioButton, manufactured by the company BioIntelliSense. Wearable, disposable devices can record information such as skin temperature, respiratory rate and body position. Devices that have been used during the COVID-19 pandemic; for example, when Colorado Medical College Distributing Pfizer-BioNTech’s vaccine for the first time For healthcare workers, it used BioButton to monitor patients’ vital signs to detect adverse reactions. BioSticker has been approved by the FDA.
